Rutherford Health - Issue of Equity London Stock Exchange
RNS Number : 9707L
Rutherford Health PLC
11 September 2019

 11 September 2019                       



Rutherford Health plc (the "Company" or "Rutherford") has issued a notice under the Woodford Commitment, referred to in the Company's NEX Exchange Growth Market ("NEX") admission document, under which it has subscribed for 7,102,273 Rutherford ordinary shares of £0.001 each ("Ordinary Shares") at the maximum possible price under that agreement of £1.76 per Ordinary Share, in order to raise £12.5 million. The funds will be to provide additional working capital for the Group.  

The allocation and resultant additional voting rights held by each of LF Woodford Equity Income Fund and Woodford Patient Capital Trust plc under the terms of the Woodford Commitment, will be notified in due course.

Settlement and Dealings

Application has been made for the admission to trading on NEX of the 7,102,273 Ordinary Shares on 16 September 2019 ("Admission").

Following Admission, the Company will have 179,700,533 Ordinary Shares in issue.

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

The directors of Rutherford Health plc accept responsibility for this announcement.


Rutherford Health plc



Michael Moran, Chief Executive Officer

Tel: +44 (0) 16 3381 0661


Grant Thornton (Corporate Adviser)

Tel: +44 (0) 20 7383 5100


Colin Aaronson/ Jamie Barklem/ Niall McDonald










This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit